Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Rapid Acting Transcranial Magnetic Stimulation for Suicide Ideation in Depression

NCT05100004 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.

NCT NCT05100004
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05100004 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Rapid Acting Transcranial Magnetic Stimulation for Suicide Ideation in Depression
Lead sponsor
Stanford University
Phase
Not applicable
Overall status
Withdrawn
Start date
November 7, 2021
Completion date
September 30, 2025
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

depressive disorder, major, suicide